Mergers and Acquisitions Support
Life sciences M&A is never just a financial exchange. It is an operational transition that can strengthen your platform or quietly introduce compliance risk, quality drift and delivery disruption. We help buyers, sellers and investors understand what they are really acquiring, translate findings into deal-relevant risk, and build integration plans that protect quality, continuity and timelines.
Sectors we support
Where We Fit
1
Pre-Close Diligence
Financial, commercial, quality, operational and documentation readiness reviews, so you know what you are buying before you commit.
2
Deal Execution Support
Data room structure, evidence packages, Q&A support and input on purchase agreements to keep the deal moving.
3
Post-Close Integration
Quality system alignment, governance and operational stabilization so the acquired business performs from day one.
Problems We Solve
Understanding Complex Value Propositions in Life Sciences
Much of the value sits off the balance sheet: platform know-how, analytical methods, supplier relationships, regulatory history and a few key people.
We translate complex scientific and operational stories into deal-relevant language, mapping the value drivers and the dependencies that must hold for that value to last.
What you get: a clearer view of what you are acquiring, and a stronger basis for valuation, risk allocation and integration priorities.
Spotting Operational and Quality Red Flags
The most expensive surprises hide in execution: weak investigations, ineffective CAPAs, uncontrolled changes, supplier gaps and data integrity issues.
We sample records, trace workflows and pressure-test the quality system where it matters, then translate findings into cost, timeline, continuity and compliance implications.
What you get: a prioritized risk picture and a realistic remediation path you can build into deal terms and integration planning.
Post-Acquisition Support
Integrations stall when parallel quality systems persist, local teams resist “corporate” processes and leadership loses visibility.
We define what must be standardized versus kept local, set governance and decision rights, and provide hands-on support to stabilize operations through the transition.
What you get: a sequenced, inspection-ready integration roadmap with owners, milestones and measurable outcomes.
How an Engagement Works
1
Free Consultation
A no-obligation call to understand the deal, your timeline and where the risk is most likely to sit.
2
Scoped Assessment
We agree a focused scope, then review the systems, records and operations that matter most for this transaction.
3
Findings and Roadmap
You receive risk-ranked findings framed by impact, and a practical plan for deal terms and integration.
Typical Deliverables
- Red-flag summary for the deal team
- Risk-ranked findings by compliance, continuity, cost and timeline impact
- Remediation scope and timeline estimates to support negotiations
- Integration roadmap with owners, milestones and governance
Our Approach
Deep Market Knowledge
Experience across the sector, from innovators to complex service providers, to inform your M&A strategy.
Risk-Based Diligence
Focus on the few systems that drive most GMP and operational risk.
Evidence-First Assessments
Record sampling, traceability checks and practical walkthroughs, not surface-level reviews.
Deal-Relevant Outputs
Findings framed by impact on compliance, continuity, cost and timeline.
Integration Built for Reality
Roadmaps that respect site constraints, culture and operational commitments.
Confidence Through Clarity
Clear priorities, owners and sequencing, so progress is measurable and auditable.
Related Services
FAQs
What does life sciences M&A support include?
It includes everything from early-stage prospecting and M&A strategy formalization to target identification, quality review, operational assessment, documentation review, due diligence, deal team support, and post-close integration planning for regulated systems and workflows.
What is GMP due diligence in an acquisition?
It is a structured, evidence-based review of a target’s quality system, manufacturing and laboratory operations, and records. It confirms how well the business actually meets GMP expectations and identifies compliance gaps, remediation costs, and risks that affect valuation, deal terms, and integration.
What are common red flags during quality diligence?
Common red flags include weak quality culture, growing deviation/CAPA and change-control backlogs, gaps in training evidence, uncontrolled changes, validation gaps, supplier quality weaknesses, data integrity issues, and “hero-based” operations where knowledge is not institutionalized. Frequent firefighting, missed timelines, unclear ownership, and teams relying on workarounds to keep output moving are also warning signs.
How do you turn diligence findings into deal decisions?
We frame findings by severity and likely impact—cost, timeline, compliance exposure, and operational disruption—so buyers can model remediation, negotiate protections, or adjust integration plans.
Can you support sellers as well as buyers?
Yes. Sellers often need help meeting potential buyers, strengthening documentation, addressing high-risk gaps, and presenting a coherent, evidence-backed story to reduce diligence friction and increase buyer confidence.
What makes post-close integration hard in regulated operations?
Different QMS structures, SOP standards, definitions of completeness, and decision rights can create parallel systems and slow adoption. Integration also competes with ongoing production, release, and audit commitments.
How do you approach multi-site integration after an acquisition?
We map system differences, define what must be standardized versus local, establish governance, and build a sequenced roadmap with owners and milestones—so integration is achievable and inspection-ready.
When should we start planning integration?
Ideally during diligence. Integration planning is most effective when risks are identified early, transition assumptions are tested, and responsibilities are clarified before close.
Planning an Acquisition or Preparing to Sell?
Whether you’re conducting diligence, preparing your business for sale, or integrating a new site, we help you move forward with clarity and confidence. Get in touch to discuss how we can support your transaction.
